Decrease in ACE2 mRNA expression in aged mouse lung
Abstract
Angiotensin-converting enzyme 2 (ACE2) has been identified as a critical receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This has led to extensive speculation on the role of ACE2 in disease severity, and in particular, whether variation in its expression can explain higher mortality in older individuals. We examine this question in mouse lung and show that 24-month old mice have significantly reduced ACE2 mRNA expression relative to 3-month old mice. The differences appear to be localized to ciliated cells.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 14
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Age-dependent regulation of SARS-CoV-2 cell entry genes and cell death programs correlates with COVID-19 disease severity
Z. Inde, C. Yapp, … K. A. Sarosiek·bioRxiv·Sep 13, 2020
- ACE2-expressing endothelial cells in aging mouse brain
Su Bin Lim, Valina Lynn Dawson, … Sung-Ung Kang·bioRxiv·Jul 11, 2020
- DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging
S. Sepe, F. Rossiello, … F. d'Adda di Fagagna·bioRxiv·Jun 9, 2021
- Neonatal hyperoxia enhances age-dependent expression of SARS-CoV-2 receptors in mice
Min Yee, Ethan David Cohen, … Michael A. O’Reilly·Scientific ReportsPeer-reviewed·Dec 28, 2020
- Alveolar early progenitors in the aged human lung have increased expression of ACE2 accompanied with genes involved in beta-amyloid clearance: Indication of SARS-CoV-2 also using soluble ACE2 in aged-lungs to enter ACE2-negative cells
Virendra K. Chaudhri·bioRxiv·May 25, 2020
- Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Joseph W. Golden, Curtis R. Cline, … Jay W. Hooper·JCI InsightPeer-reviewed·Oct 2, 2020